ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 685503 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 685503; 2) Community: the network communities that were significantly associated with the response to NSC 685503; 3) Molecule: the relationships between components within communities and NSC 685503; 4) MDR: the compounds that were significantly associated with the NSC 685503.

NSC Compound Enrichment Correlation
NSC 718564 Null 0.0401206532535671 0.14598513
NSC 718781 Erlotinib hydrochloride 0.0401206532535671 -0.15445682
NSC 719667 7-methoxy-8-[3-(1,4-oxazinan-4-yl)propoxy-(11aS)-2,3,5,11a -tetrahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepine-5-one 0.0401206532535671 0.26491499
NSC 720320 1,6-bis-(2,6-difluorobenzyl)-2-(2,6-difluorophenyl)-5-methoxy-benzimidazole 0.0401206532535671 -0.0018811626
NSC 726217 Combretastatin A4-analogue 0.0401206532535671 0.42980572
NSC 726442 4,11-dihydroxy-3-{[4-(2-hydroxyethyl)-1-piperazinyl]methyl}- 1H-naphtho[2,3-f]indole-5,10-dione dihydrochloride 0.0401206532535671 0.29210753
NSC 744688 Null 0.0401206532535671 0.32257306
NSC 748902 [(20S)-20-(N,N-dimethylamino)- 3a-(tigloylamino)-5a-preg-2a-ol] 0.0401206532535671 0.16799563
NSC 761832 (Z)-3-((1-(3,5-dimethoxyphenyl)-9H-pyrido[3,4-b]indol-3-yl)methylene)-5-methoxyindolin-2-one 0.0401206532535671 0.21794006
NSC 762346 Null 0.0401206532535671 0.23313662
Total:91  Current:82    [First] [Prev] [Next] [Last]